Intralesional and perilesional treatment of skin cancers

Christopher J. Arpey, Nicole M. Annest, Stephen B. Tucker, Erik T. Petersen, Ronald P. Rapini, Deborah F. MacFarlane

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

In this chapter, various intralesional and perilesional agents that have been used in the treatment of skin cancers are presented by practitioners familiar with their use. The four medications reviewed have been in widespread use for many years in the treatment of cutaneous neoplasms and extracutaneous neoplastic and inflammatory conditions. Therefore, the efficacy, toxicity, delivery, indications, and costs for these agents are well established, and they are widely available. However, the most common routes of administration for such medications are oral, intravenous, and topical. An intralesional and perilesional approach to therapy is less often utilized, leading to less familiarity in clinical practice. It is our hope that a detailed review of these agents delivered in such a manner, along with a variety of clinical examples, will facilitate their use in practice and increase the variety of treatment options available to patients with cutaneous tumors.

Original languageEnglish (US)
Title of host publicationSkin Cancer Management
Subtitle of host publicationA Practical Approach
PublisherSpringer International Publishing
Pages63-91
Number of pages29
ISBN (Electronic)9783030505936
ISBN (Print)9783030505929
DOIs
StatePublished - Apr 26 2021

Keywords

  • 5-Fluouracil
  • Bleomycin
  • Interferon
  • Intralesional injection
  • Methotrexate

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Intralesional and perilesional treatment of skin cancers'. Together they form a unique fingerprint.

Cite this